Senior insider sale
Chief Technology Officer at KYVERNA THERAPEUTICS, INC. — senior position signals high conviction
$210.7K
24K shares
What this filing means
WALKER KAREN MARIE plans to sell 24K shares of KYVERNA THERAPEUTICS, INC. valued at approximately $210.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/15/2025ACC: 0001950047-25-010307
Officer· Chief Technology Officer
Since Feb 2024
24K
Shares to sell
$210.7K
Approx. market value
24K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
12/15/2025
24KTotal acquired24K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/15/2025 | Exercise of Stock Options Cash | 24K | — |
| Total | 24K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
24K
Market value
$210.7K
12/15/2025
Total
Units
24K
Value
$210.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
12/15/2025 | 24K | $210.7K | NASDAQ | Planned |
| Total | 24K | $210.7K | ||